- Home
- XLO vs USIO Comparison
XLO vs USIO Comparison
Compare XLO & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XLO
- USIO
- Stock Information
- Founded
- XLO 2016
- USIO 1998
- Country
- XLO United States
- USIO United States
- Employees
- XLO N/A
- USIO N/A
- Industry
- XLO Biotechnology: Pharmaceutical Preparations
- USIO Investment Bankers/Brokers/Service
- Sector
- XLO Health Care
- USIO Finance
- Exchange
- XLO Nasdaq
- USIO Nasdaq
- Market Cap
- XLO 42.2M
- USIO 37.1M
- IPO Year
- XLO 2021
- USIO N/A
- Fundamental
- Price
- XLO $0.74
- USIO $1.76
- Analyst Decision
- XLO Buy
- USIO Strong Buy
- Analyst Count
- XLO 1
- USIO 1
- Target Price
- XLO $4.00
- USIO $4.00
- AVG Volume (30 Days)
- XLO 416.8K
- USIO 106.9K
- Earning Date
- XLO 08-07-2025
- USIO 08-13-2025
- Dividend Yield
- XLO N/A
- USIO N/A
- EPS Growth
- XLO N/A
- USIO N/A
- EPS
- XLO N/A
- USIO 0.12
- Revenue
- XLO $9,274,000.00
- USIO $83,970,504.00
- Revenue This Year
- XLO $300.08
- USIO $16.33
- Revenue Next Year
- XLO $1.87
- USIO $14.56
- P/E Ratio
- XLO N/A
- USIO $15.88
- Revenue Growth
- XLO N/A
- USIO 0.46
- 52 Week Low
- XLO $0.62
- USIO $1.24
- 52 Week High
- XLO $1.70
- USIO $2.92
- Technical
- Relative Strength Index (RSI)
- XLO 55.04
- USIO 69.34
- Support Level
- XLO $0.67
- USIO $1.55
- Resistance Level
- XLO $0.70
- USIO $1.69
- Average True Range (ATR)
- XLO 0.03
- USIO 0.09
- MACD
- XLO 0.01
- USIO 0.02
- Stochastic Oscillator
- XLO 98.84
- USIO 89.19
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).
About USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.